Tags |
|
|
Links |
|
|
Advice Pool - Globalization for Americans - Nu Leadership Series
“ Every failure is a blessing in disguise, providing it teaches some needed lesson one could not have learned without it. Most so-called Fa
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ilures are only temporary defeats.”
Napoleon Hill
The American flag blows. White picket fences stand. Can you smell the hot appl
Napoleon Hill
The American flag blows. White picket fences stand. Can you smell the hot appl
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
e pie? Some American enthusiasts claim that transferring Western values to the world should be easy. Clearly, this is far from the truth when
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
you consider how Westerners view organizational design from a global context. First, there is the barrier of perception. Many foreigners are r
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
eluctant to embrace Western values primarily due to the Western reputation of superiority. Second, there is the barrier of culture. In dealing
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
with varying cultures, some common differences lie in the way cultures perceive time, thought patterns, personal space, material possessions,
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
relationships, competitiveness, social behavior, individuality, and other interrelated problems.
Third, organizations must deal with uncerta
Third, organizations must deal with uncerta
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
inty. There are two kinds of global companies, which are the multidomestic company and the global corporation. The multidomestic company pursu
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
es different strategies in each of its foreign markets while a global company views the world as one market. The critical factors include stru
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
cture, management processes, culture, and people. In dealing with structure, there is a concern about implementing a centralized global author
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ity with the rifts between domestic and international departments. Peter and Donnelly, authors of A Preface to Marketing Management, ma
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
intain that there are several factors, including structure and culture, that impede or facilitate a company globally.
When entering foreign m
When entering foreign m
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
arkets, circumstances change. Issues that may exist include (a) cultural misunderstandings, (b) political uncertainty, (c) import restrictions
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
, (d) exchange controls, and (e) economic conditions. Management guru Galbraith argues that organizations operating globally must live with st
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ructural indeterminacy where no single structure is the ultimate solution. Some businesses utilize management analysis such as PEST or SWOT t
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
o assist them in steering away from the troublesome landmines. Clearly, organizations cannot simply implementing Western structures into othe
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
r cultures without engaging in strategic thinking. Galbraith further maintains that these companies must understand their competitors and dete
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
rmine if they can transfer their competitive advantage in another country’s environment. Therefore, American managers must seek to understand
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
their foreign employees and the countries cultural norms.
References:
Galbraith, J. (1997). Designing the Global Corporation. San Fra
References:
Galbraith, J. (1997). Designing the Global Corporation. San Fra
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ncisco, CA: Jossey-Bass.
Peter, J. & Donnelly, J. (2003). A Preface to Marketing Management. New York: McGraw-Hill.
© 2007 by Daryl D. Green
Peter, J. & Donnelly, J. (2003). A Preface to Marketing Management. New York: McGraw-Hill.
© 2007 by Daryl D. Green
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/290623/advicepool-Globalization-for-Americans--Nu-Leadership-Series.html">Globalization for Americans - Nu Leadership Series</a>
BB link (for phorums):
[url=http://www.advicepool.org.ua/article/290623/advicepool-Globalization-for-Americans--Nu-Leadership-Series.html]Globalization for Americans - Nu Leadership Series[/url]
Related Articles:
Job Security Trends: Why Are People Changing Jobs?
How To Manage Your Arthritis Pain
Bookmark it:
|